癌症免疫疗法的免疫媒介副作用
Lukas M Braun1, Jarushka Naidoo2, Robert Zeiser1
1University Medical Center Freiburg, Freiburg, Germany.
Blood
|March 9, 2026
概括
癌症免疫疗法提供了强大的治疗方法,但可以导致严重的免疫相关副作用,如GVHD和CRS. 本综述探讨了这些毒性,它们的潜在生物学,以及管理它们的新兴疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 癌症免疫疗法,如CAR-T细胞疗法和免疫检查点抑制剂,已经彻底改变了癌症治疗.
- 尽管有效,但这些疗法与显著的免疫中介毒性有关.
- 了解这些副作用对于改善患者的结果和扩大治疗应用至关重要.
研究的目的:
- 讨论癌症免疫疗法的各种免疫媒介副作用之间的生物学相似性和差异.
- 审查当前和未来的治疗策略来管理这些毒性.
- 增强对各种免疫相关不良事件背后的共享病理生理机制的理解.
主要方法:
- 关于癌症免疫疗法相关毒性的当前文献的综述.
- 对移植与宿主疾病 (GVHD),细胞因子释放综合征 (CRS),免疫效应细胞相关神经毒性综合征 (ICANS) 和免疫相关不良事件 (irAEs) 的病理生理学的比较分析.
- 关于免疫介导副作用的批准,评估和潜在的未来疗法的摘要.
主要成果:
- 鉴定了髓状细胞和T细胞,包括组织居民T细胞在GVHD,CAR-T细胞毒性和irAEs的致病性中的关键作用.
- 详述了各种免疫相关不良事件的生物学特征,包括急性GVHD,CRS,ICANS,IEC-HS,ICAHT,LICATS和irAEs.
- 强调需要治疗策略,以解决这些多样化毒性背后的共同机制.
结论:
- 免疫介导的副作用的有效管理对于癌症免疫疗法的成功应用至关重要.
- 针对共享的病理生理路径为开发针对这些毒性的新疗法提供了一个有希望的方法.
- 进一步研究免疫细胞在免疫疗法诱导的毒性中的复杂相互作用,将指导开发更安全,更有效的治疗方法.
相关概念视频
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
01:40Cell-mediated Immune Responses
85.5K
Overview
85.5K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
629
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
629